Bowel Management Systems Market (2026 - 2033)

Bowel Management Systems Market Summary

The global bowel management systems market size was valued at USD 1.8 billion in 2025 and is projected to grow from USD 1.9 billion in 2026 to USD 2.4 billion in 2033, at a CAGR of 3.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 36.0% in 2025. This growth is attributed to the increasing prevalence of bowel-related disorders and conditions, such as inflammatory bowel disease, fecal incontinence, and colorectal cancer. In addition, the growing geriatric population, who are more susceptible to bowel dysfunction, is also contributing to market growth. Furthermore, technological advancements in bowel management devices, including improved irrigation systems, ostomy bags, and nerve modulation devices, enable more effective treatment options and drive adoption.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Bowel management is a significant and often time-consuming issue for an increasing number of patients with spinal cord injury. However, worldwide, the elderly population is the fastest-growing segment, leading to severe problems. Children with spina bifida often face bowel-related challenges, such as constipation and incontinence, due to various factors. Neurological abnormalities associated with the condition can lead to a lack of bowel control, weak abdominal muscles, and reduced physical activity. Furthermore, dietary factors, including insufficient fiber intake, contribute to constipation. As these individuals grow older, they may experience age-related changes in bowel function, which can exacerbate existing issues or introduce new complications.

In addition, these are temporary containment devices designated for disabled or immobilized incontinent patients with less or no bowel control, having a liquid or semi-liquid stool, and persistent diarrhea. In addition, the increasing geriatric population, growth in target patient volumes, rising rates of gastrointestinal diseases and pelvic floor dysfunction, and the accessibility of technologically enhanced bowel management systems, coupled with favorable reimbursement conditions in various countries, drive market growth. For instance, in September 2025, a leading medical device company, such as Coloplast Group, strengthened its long-term strategy to expand its continence and chronic care solutions, reflecting rising global demand for bowel management and related patient care systems.

Furthermore, the growing elderly population increases demand for efficient bowel management. The management preferences include oral and/or anal medication, digital stimulation, or manual evacuation; hence, the rising prevalence of fecal incontinence, pelvic floor dysfunctions, and age-related muscle weaknesses results in market growth for the bowel management system market across the world.

Analyst Perspective

The bowel management systems market is experiencing steady growth, driven by the rising prevalence of bowel disorders such as fecal incontinence, constipation, inflammatory bowel disease, and colorectal conditions, alongside the rapidly expanding geriatric population and increasing incidence of neurological disorders and post-surgical complications. Demand is further supported by growing awareness of continence care, improved acceptance of advanced bowel management devices, and the expansion of homecare and hospital-based treatment infrastructure. Technological advancements in irrigation systems, ostomy care solutions, and neuromodulation-based therapies are enhancing patient comfort and clinical effectiveness, thereby accelerating adoption. North America leads due to strong reimbursement systems and high treatment adoption, while Europe benefits from an aging population and advanced healthcare infrastructure, and Asia-Pacific shows strong growth potential driven by improving healthcare access and rising disease burden.

Type Insights

Colostomy bags dominated the market, accounting for the largest revenue share of over 45.0% in 2025. This growth is attributed to the rising prevalence of colorectal cancer, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, and the growing geriatric population, who are more susceptible to these conditions, are major drivers. In addition, the technological advancements in colostomy bags, such as sensors to detect leakage and improved designs for patient comfort, enable better treatment options and drive adoption. Increased patient awareness, strong acceptance of developed products, and new investments in R&D and manufacturing are further propelling global growth in the colostomy bags market.

The nerve modulation devices are projected to grow at a significant CAGR over the forecast period. This growth is driven by the increasing prevalence of bowel disorders, such as fecal incontinence, which has heightened the demand for effective treatment options. In addition, the rapidly aging population, which is more susceptible to bowel dysfunction, is contributing to market expansion. In addition, technological advancements in nerve modulation devices, including improved efficacy and patient comfort, are also significant drivers. Furthermore, favorable reimbursement policies in developed regions enhance accessibility, encouraging healthcare providers to adopt these innovative solutions for bowel management.

Patient Type Insights

Adult patients led the market, accounting for the largest revenue share at approximately 68.0% in 2025. This growth is attributed to the rising prevalence of colorectal cancer; individuals with symptoms of inability to control bowel movements, inadequate emptying, or chronic constipation benefit from bowel management systems. This prevents constipation and decreases unpredictable elimination. In addition, patient awareness, rising adoption of bowel management systems, increasing investments in product development and innovation, well-established healthcare infrastructure, and the widespread adoption of developed products are key factors driving market growth. For instance, in March 2026, the Canadian Nurses Association hospital-wide bowel management protocols were increasingly implemented to address constipation and bowel dysfunction among elderly, post-surgical, and immobilized patients, with structured stepwise interventions improving patient outcomes and reducing complications. Recent clinical practices highlight the growing adoption of standardized bowel care pathways, further supporting the need for effective bowel management systems in healthcare settings.

The pediatric patient segment is expected to grow at a high CAGR during the forecast period. Major factors for the increase in pediatric sections are emerging cases of children with spina bifida (SB) dealing with bowel problems nowadays, such as constipation and incontinence. Other aspects include advancements in healthcare technology and research that have improved the understanding and treatment of pediatric bowel problems, such as short bowel syndrome (SBS) and inflammatory bowel disease (IBD). Moreover, innovations in enteral and parenteral nutrition have enhanced the ability to support pediatric patients with severe bowel dysfunction, promoting better growth and development outcomes.

End Use Insights

The home care segment held the largest revenue share, approximately 58.5%, in 2025, owing to the significant usage and rising adoption of bowel management systems in home care settings. For instance, in March 2026, Minnesota Medical Technologies Corporation secured USD 20.6 million in Series A funding to commercialize its StaySure Fecal Incontinence Insert System. Developed in collaboration with Mayo Clinic gastroenterologists, this single-use insert serves as a discreet alternative to traditional absorbent pads. The rollout directly targets home care and ambulatory care paths, driving market expansion by offering automated, comfortable pelvic management that reduces the dependency on manual hospital procedures. In addition, the need for regular device replacement and the rising prevalence of chronic disorders drive the segment's growth.

Hospitals and ambulatory surgery centers are expected to grow at a CAGR over the projected years. This growth is attributed to technological advancements in treatment, with bowel management systems, procedures, and digital imaging enabling complex surgeries to be performed in ambulatory centers that were previously conducted in hospitals. This shift is driven by the cost-effectiveness and efficiency of ambulatory surgery centers, which offer high-quality care at lower costs. In addition, the rising prevalence of chronic disorders demanding surgical interventions boosted the demand for both hospitals and ambulatory surgery centers.

Regional Insights

North America bowel management systems market dominated the global market and accounted for the largest revenue share of over 36.0% in 2025. This growth is attributed to the rising prevalence of bowel disorders, particularly among the aging population. In addition, increased awareness of bowel management options and the availability of advanced products enhance adoption rates. Furthermore, a well-established healthcare infrastructure and favorable reimbursement policies facilitate access to these systems. The presence of major market players and ongoing innovations in product development further propel the expansion of this market segment in the region. For instance, in March 2025, Convatec announced an exclusive collaboration with the Wound, Ostomy and Continence Nurses Society (WOCN), the largest professional nursing organization dedicated to wound, ostomy, and continence care. Through this partnership, Convatec launched educational initiatives in the U.S., including the Advanced Ostomy Care Program and the Ostomy Care Associates (OCA) Program, aimed at improving healthcare professional training and expanding access to specialized ostomy and continence care. This development highlights increasing awareness, strong healthcare infrastructure, and continued investment in advanced bowel and continence care across North America.

To learn more about this report, Download Free Sample Report

U.S. Bowel Management Systems Market Trends

The bowel management systems market in the U.S. dominated the North American market and accounted for the largest revenue share in 2025. The primary drivers for the U.S. market include improved healthcare infrastructure, rising adoption of intestinal management systems, rising patient awareness, and widespread acceptance of enhanced products, which are major factors ensuring the region's dominance.

Asia Pacific Bowel Management Systems Market Trends

The Asia-Pacific bowel management systems market is expected to grow at a CAGR over the forecast period. The growing awareness of its treatment in China, India, Japan, and other countries influenced market expansion. Furthermore, the aging population in Asian countries primarily drives market growth.

The bowel management systems market in China is expected to grow substantially over the forecast years, owing to the large targeted patient population, increased awareness of improved internal bowel management systems, mounting demand for healthcare infrastructure, a surge in hospitals in the country, robust R&D sector expansion, and an increase in healthcare reforms.

The Indian bowel management systems market is expected to experience rapid growth over the projected years. This growth is expected to be driven by the increasing population and disorders associated with constipation and incontinence. Furthermore, the growing number of hospitals in emerging countries and the rising demand for healthcare infrastructure are the primary drivers of market growth. For instance, in February 2025, Apollo Hospitals announced plans to add approximately 3,500 beds across India over the next few years as part of its healthcare expansion strategy. The initiative aims to strengthen healthcare infrastructure and improve access to specialized medical services across both metropolitan and emerging cities. Such investments are expected to enhance the availability of advanced gastrointestinal and continence care services, supporting the adoption of bowel management solutions in the country.

Europe Bowel Management Systems Market Trends

The European bowel management systems market is expected to witness significant growth in the global market over the forecast years. This growth is driven by the rapid growth of the geriatric population and a growing patient population requiring effective bowel management solutions, further fueling market expansion. Furthermore, favorable reimbursement policies in many European countries improve access to these systems, promoting their adoption in both clinical and home care settings.

The bowel management system market in the UK is led by the rising occurrence of bowel disorders among citizens, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), which has increased the demand for effective management solutions. For instance, in September 2025, Central London Community Healthcare NHS Trust (CLCH) launched a dedicated Pediatric Bladder and Bowel Continence Service in Brent to provide specialized support for patients experiencing bowel dysfunction, constipation, and continence-related conditions. The initiative aims to improve access to bowel care services and enhance patient outcomes through targeted continence management programs. The aging population is another crucial factor, as older people are more prone to bowel dysfunctions, necessitating advanced management systems. Furthermore, technological advancements in bowel management products, including more efficient and patient-friendly devices, have also contributed to market growth.

Key Bowel Management Systems Company Insights

Some of the key companies in the bowel management systems market include Convatec Inc., BD, ProSys International Ltd, Suzhou Shenyun Medical Equipment Co., Ltd, Coloplast, Consure Medical, Axonics, Inc., SAYCO PTY LTD; in the market & are focusing on continuous development and innovation to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

• Welland Medical Ltd. manufactures essential healthcare equipment. They specialize in developing and manufacturing stoma care appliances and accessories. Moreover, they offer mobility healthcare equipment to assist day-to-day living, such as walking frames, three-wheeled walkers, ramps, rollators, and other significant medical equipment.

• Convatec is a global medical products and technologies company that specializes in solutions for managing chronic conditions. The company holds leading market positions in several key areas, including advanced wound care, ostomy care, continence and critical care, and infusion care. Convatec's product portfolio encompasses a wide range of products designed to improve patient outcomes and reduce the total cost of care.

Key Bowel Management Systems Companies

The following key companies have been profiled for this study on the bowel management systems market:

• Convatec Inc.

• BD

• ProSys International Ltd

• Suzhou Shenyun Medical Equipment Co., Ltd

• Coloplast

• Consure Medical.

• Axonics, Inc.

• SAYCO PTY LTD

• Qufora

• Hollister Incorporated

• Wellspect HealthCare, a Dentsply Sirona Company.

• Welland Medical Limited.

Recent Developments

• In May 2025, Axena Health, Inc. announced that its Leva Pelvic Health System became available to female veterans through federal healthcare providers. The expansion improves access to non-invasive pelvic floor therapy for women experiencing urinary and bowel dysfunction, highlighting growing efforts to enhance continence care and broaden the availability of innovative pelvic health solutions.

• In November 2024, Boston Scientific completed its acquisition of Axonics, Inc., a medical technology company specializing in sacral neuromodulation (SNM) therapies and devices for urinary and bowel dysfunction. The acquisition strengthened Boston Scientific's urology and pelvic health portfolio by expanding its access to innovative therapies for fecal incontinence and bowel dysfunction, reinforcing the company's position in the bowel management market through a broader range of advanced treatment solutions.

Global Bowel Management Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bowel management systems market report based on type, patient type, end use, and region:

• Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Colostomy Bags
  • Irrigation Systems
  • Nerve Modulation Devices
  • Others
• Patient Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Adult
  • Pediatric
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Home Care
  • Hospitals and Ambulatory Surgery Centers
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait